Knowles Julius
Director at KROS
- Sold, on record
- $28.8M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Jun 4, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KROSKeros Therapeutics, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KROSUnusualSep 27, 2021 2021
Sold 95,302 shares at $41.17 ($3.9M)
Knowles Julius, Director
Sold 23.6% of holdings ($16.6M position)307,966 shares left3.7x usual sizeFiling
- 2 Form 4 sale KROSPlan not statedOct 5, 2021 +8 days
Sold 12,686 shares at $40.10 ($509k)
Knowles Julius, Director
Sold 4% of holdings ($12.7M position)302,958 shares left0.4x usual sizeFiling
- 3 Form 4 sale KROSPlan not statedOct 18, 2021 +13 days
Sold 26,367 shares at $38.56 ($1M)
Knowles Julius, Director
Sold 8.3% of holdings ($12.3M position)292,550 shares left1x usual sizeFiling
- 4 Form 4 sale KROSPlan not statedOct 20, 2021 +2 days
Sold 8,598 shares at $38.20 ($328k)
Knowles Julius, Director
Sold 2.9% of holdings ($11.4M position)289,156 shares left0.3x usual sizeFiling
- 5 Form 4 sale KROSPlan not statedNov 3, 2021 +14 days
Sold 47,651 shares at $42.12 ($2M)
Knowles Julius, Director
Sold 15% of holdings ($13.4M position)270,346 shares left1.9x usual sizeFiling
- 6 Form 4 sale KROSPlan not statedDec 2, 2021 +29 days
Sold 47,651 shares at $54.09 ($2.6M)
Knowles Julius, Director
Sold 15.9% of holdings ($16.2M position)251,536 shares left1.8x usual sizeFiling
- 7 Form 4 sale KROSPlan not statedJan 5, 2022 +34 days
Sold 47,651 shares at $57.84 ($2.8M)
Knowles Julius, Director
Sold 17% of holdings ($16.2M position)232,727 shares left1.7x usual sizeFiling
- 8 Form 4 sale KROSRoutineJun 4, 2026 +1611 days
Sold 2,625 shares at $10.73 ($28k)
Knowles Julius, Director
10b5-1 planSold 19.3% of holdings ($146k position)10,958 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8, 2026 | KROS | Director | Form 4 sale | 2,625 | $28k | 19.3% | Routine | SEC |
| Jan 5, 2022 | Jan 5, 2022 | KROS | Director | Form 4 sale | 47,651 | $2.8M | 17.0% | Plan not stated | SEC |
| Dec 2, 2021 | Dec 3, 2021 | KROS | Director | Form 4 sale | 47,651 | $2.6M | 15.9% | Plan not stated | SEC |
| Nov 3, 2021 | Nov 3, 2021 | KROS | Director | Form 4 sale | 47,651 | $2M | 15.0% | Plan not stated | SEC |
| Oct 20, 2021 | Oct 21, 2021 | KROS | Director | Form 4 sale | 8,598 | $328k | 2.9% | Plan not stated | SEC |
| Oct 18, 2021 | Oct 18, 2021 | KROS | Director | Form 4 sale | 26,367 | $1M | 8.3% | Plan not stated | SEC |
| Oct 5, 2021 | Oct 5, 2021 | KROS | Director | Form 4 sale | 12,686 | $509k | 4.0% | Plan not stated | SEC |
| Sep 27, 2021 | Sep 29, 2021 | KROS | Director | Form 4 sale | 95,302 | $3.9M | 23.6% | Unusual | SEC |
| Jul 2, 2021 | Jul 6, 2021 | KROS | Director | Form 4 sale | 47,652 | $2M | 12.1% | Plan not stated | SEC |
| Jun 7, 2021 | Jun 8, 2021 | KROS | Director | Form 4 sale | 19,415 | $953k | 5.1% | Plan not stated | SEC |
| Jun 3, 2021 | Jun 3, 2021 | KROS | Director | Form 4 sale | 28,236 | $1.4M | 7.1% | Plan not stated | SEC |
| May 4, 2021 | May 5, 2021 | KROS | Director | Form 4 sale | 47,651 | $2.7M | 11.1% | Plan not stated | SEC |
| Apr 6, 2021 | Apr 8, 2021 | KROS | Director | Form 4 sale | 9,298 | $547k | 2.3% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 5, 2021 | KROS | Director | Form 4 sale | 38,353 | $2.3M | 8.6% | Plan not stated | SEC |
| Mar 4, 2021 | Mar 5, 2021 | KROS | Director | Form 4 sale | 23,959 | $1.4M | 5.4% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 3, 2021 | KROS | Director | Form 4 sale | 23,690 | $1.4M | 5.2% | Plan not stated | SEC |
| Feb 18, 2021 | Feb 18, 2021 | KROS | Director | Form 4 sale | 28,617 | $1.7M | 6.1% | Plan not stated | SEC |
| Feb 12, 2021 | Feb 16, 2021 | KROS | Director | Form 4 sale | 19,029 | $1.2M | 4.0% | Plan not stated | SEC |